INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/17/2024
Back to search
Official data from USPTO
RECIPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
03/17/2024
Trademark type
Combined
Nice classes
5, 42
Filing date
09/23/2010
Registration date
11/29/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2023
Last transaction
05/31/2023
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
STOCKHOLM, SE
Examiner
MAKHDOOM,SAIMA
Law office
L10
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the word "RECIPHARM" appearing in turquoise with a turquoise flag above the letter "h" in the mark.
Holders and representatives
Holders
Recipharm AB (publ)
Recipharm AB (publ)
Representatives
Richard J. McKenna FOLEY & LARDNER LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsantibacterial pharmaceuticalsanti-diabetic pharmaceuticalsbalms for pharmaceutical purposescardiovascular pharmaceuticalsdermatological pharmaceutical productsdigestives for pharmaceutical purposesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsinhaled pharmaceutical preparations for the treatment of respiratory diseases and disordersocular pharmaceuticalspharmaceutical anti-allergic preparations and substancespharmaceutical anti-allergic preparations and substancesanticoagulantsantidepressantsappetite suppressantspharmaceutical preparations for use in chemotherapypharmaceutical preparations for the treatment of heart rhythm disorderspharmaceutical preparations for the treatment of infectious diseasespharmaceutical preparations acting on the central nervous systempharmaceutical preparations and substances for the treatment of gastro-intestinal diseasespharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosispharmaceutical preparations for treating diabetespharmaceutical preparations for woundspharmaceutical preparations for use in urologypharmaceutical preparations for skin carepharmaceutical preparations for the treatment of kidney diseasespharmaceutical preparations and substances for the treatment of psychiatric diseases and disorderspharmaceutical preparations for the treatment of the thyroid gland
Class 42
Medical research laboratory services; consultation services related to research in the field of development of surgical products; product development; development of medical products; and scientific and technological services and research and design relating thereto for medical purposesmedical and scientific research in the fields of cancer treatmentcardiovascular treatmenttreatment of infectious diseasestreatment of a wide variety of major medical human disorders
Publications
History of USPTO decisions and trademark events.
48 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/07/2024
INPC
INVALIDATION PROCESSED
02/07/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/31/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/31/2023
71AG
REGISTERED-SEC.71 ACCEPTED
05/31/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/17/2023
PR71
POST REGISTRATION ACTION MAILED - SEC.71
11/02/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/24/2022
ES71
TEAS SECTION 71 RECEIVED
05/10/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/29/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/06/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/30/2020
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/12/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/05/2018
INPC
INVALIDATION PROCESSED
09/05/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/17/2018
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/04/2017
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
12/04/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/01/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/16/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
11/08/2017
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/29/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/10/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/23/2012
FIMP
FINAL DISPOSITION PROCESSED
07/23/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/29/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2011
GPNX
NOTIFICATION PROCESSED BY IB
11/20/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2011
PUBO
PUBLISHED FOR OPPOSITION
09/13/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/24/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/24/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/11/2011
ALIE
ASSIGNED TO LIE
08/11/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2011
RFNT
REFUSAL PROCESSED BY IB
01/29/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/11/2011
RFRR
REFUSAL PROCESSED BY MPU
01/11/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/10/2011
CNRT
NON-FINAL ACTION WRITTEN
01/09/2011
DOCK
ASSIGNED TO EXAMINER
12/31/2010
MAFR
APPLICATION FILING RECEIPT MAILED
11/23/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/19/2010
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/18/2010
Continuous trademark protection
Get notified about every new filing that threatens RECIPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.